Overweight clinical trials
The registry lists 3,613 studies for Overweight across more than 10 countries. 861 are recruiting or about to start. 451 of them are mainly about Overweight (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-16. Counting its 8 narrower conditions too, such as Obesity: 13,916 studies, 2,423 open.
ClinicalTrials.gov finds 14,313 studies for Overweight. How that becomes 3,608 here
This page counts the studies the registry files under Overweight, and those it files under no condition that list Overweightthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 15, 2026. How condition pages count
- 14,313Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
- −10,173Filed under a narrower condition, counted on its own pageObesity 8,348 · Pediatric Obesity 760 · Obesity, Morbid 668 · Obesity, Abdominal 173 · Prader-Willi Syndrome 110 · Obesity Hypoventilation Syndrome 61 · 2 more
- −11List Overweight as a condition, but the registry did not file them under itMost often written as “Overweight Adolescents” (4), “Overweight and/or Obesity” (4), and “Body Weight in the Overweight and Obese Class - I Population” (3). The registry filed them under other conditions only, most often Body Weight (3) and Motor Activity (2).
- −521Match it another way511 name it in the title, 8 in a keyword, and 2 by a synonym or other text the search reads.
- 3,608The count on this page32 of them list Overweight in their own words; the registry filed them under no condition.
Get an email when these change. Save the Overweight studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Status
Who runs them
Novo Nordisk A/S (99) · Eli Lilly and Company (93) · Maastricht University Medical Center (41) · University of California, San Diego (33) · University of North Carolina, Chapel Hill (32) · Pfizer (31) · University of Colorado, Denver (30) · Massachusetts General Hospital (27)
What is being tested here
Drugs under test in Overweight studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Tirzepatide | 28 | 17 | 51 |
| Semaglutide | 24 | 21 | 52 |
| Eloralintide | 13 | 7 | 20 |
| Zenagamtide | 12 | 9 | 17 |
| Berobenatide | 11 | 12 | 20 |
| Maridebart cafraglutide | 8 | 10 | 25 |
| Mazdutide | 6 | 2 | 11 |
| Cagrilintide | 5 | 8 | 19 |
| Enicepatide | 5 | 4 | 7 |
| UBT251 | 5 | 1 | 6 |
Drug classes tested here GLP-1 receptor agonists 58 open · SGLT2 inhibitors 2 open · Statins 2 open · Angiotensin receptor blockers (ARBs) 1 open · Serotonin receptor agonists 9
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Nov 2026A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight · Phase 3 · Eli Lilly and Company
- Nov 2026A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight · Phase 3 · Eli Lilly and Company
- Dec 2026The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED) · Phase 3 · University of Virginia
- Dec 2026A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) · Phase 3 · Innovent Biologics (Suzhou) Co. Ltd.
- Dec 2026Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes Mellitus · Phase 3 · HK inno.N Corporation
- Jan 2027Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight · Phase 3 · Amgen
- Jan 2027Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight · Phase 3 · Amgen
- Feb 2027A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) · Phase 3 · Eli Lilly and Company
- Feb 2027Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1) · Phase 3 · Hudson Biotech
- Apr 2027Efficacy and Safety of Maridebart Cafraglutide in Adult Participants in Japan Who Have Obesity Disease · Phase 3 · Amgen
Who these studies take
Of the 534 Overweight studies recruiting now, 159 (30%) set no upper age limit and 347 (65%) stop at 75 or younger. 64 (12%) take children under 18. 50 (9%) are for women only and 9 (2%) for men only; 205 (38%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 33 (6%) | 31 (6%) |
| 18 | 403 (75%) | 376 (70%) |
| 30 | 438 (82%) | 409 (77%) |
| 40 | 445 (83%) | 413 (77%) |
| 50 | 427 (80%) | 402 (75%) |
| 65 | 348 (65%) | 337 (63%) |
| 75 | 231 (43%) | 223 (42%) |
| 85 | 167 (31%) | 159 (30%) |
Across all 3,613 studies, recruiting or not: 72% stop at 75 or younger and 57% at 65; 15% take children; 13% are for women only and 3% for men only; 50% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Overweight studies take
Of 231 phase 1 interventional studies under Overweight, half reached primary completion within 9 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 9 mo5–16 · 231 studies | 8 mo5–14 · 212 studies | — |
| Phase 1/2 | 15 mo12–34 · 24 studies | — | — |
| Phase 2 | 13 mo8–21 · 148 studies | 12 mo8–16 · 102 studies | 35 mo12–69 · 46 studies |
| Phase 2/3 | 47 mo31–59 · 12 studies | — | — |
| Phase 3 | 21 mo17–27 · 136 studies | 21 mo17–27 · 127 studies | — |
| Phase 4 | 25 mo13–42 · 48 studies | — | — |
| Interventional, no phase | 17 mo8–38 · 1,420 studies | 11 mo6–25 · 112 studies | 18 mo8–39 · 1,308 studies |
| Observational | 38 mo15–91 · 171 studies | — | 43 mo17–121 · 153 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 18, 2026.
Started recruiting24
- GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort StudyNov 16, 2026NCT07588984
- A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in People With Reduced Liver Function and Normal Liver FunctionNov 10, 2026NCT07587710
- Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or ObesityNov 10, 2026NCT07830329
- Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or OverweightNov 9, 2026NCT07871409
- A Study to Learn About Safety and Effects of Once-monthly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JM)Nov 6, 2026NCT07794774
Show 19 moreShow fewer
- A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Monthly Compared to Placebo in Chinese Adults With Overweight or ObesityNov 6, 2026NCT07874633
- A Study to Learn How Different Forms of the Study Medicine Called Berobenatide is Taken up Into the Blood in Adults With Overweight or ObesityNov 6, 2026NCT07876531
- Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 DiabetesNov 5, 2026NCT07866066
- Study of UBT37034 InjectionNov 5, 2026NCT07873645
- Confident Moves Intervention Efficacy Trial: Obesity Care SettingsNov 4, 2026NCT07623772
- Body-Based and Mind-Based Regulation in Overweight and Obese WomenNov 4, 2026NCT07738263
- Dance-Based Exercise Versus Clinical Pilates in Women With Overweight or ObesityNov 4, 2026NCT07745166
- A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 DiabetesNov 4, 2026NCT07881458
- SHIFT-TB: Nutrition Intervention and EvaluationNov 3, 2026NCT07836322
- Safety and Analgesic Efficacy of the Biased μ-Opioid Receptor Agonist Tegileridine for Post-Operative Analgesia in Patients Undergoing Bariatric SurgeryNov 3, 2026NCT07844512
- Effects of Concurrent Training on Serum PCSK9 Levels in Adults With OverweightNov 3, 2026NCT07910916
- FutureShape FamilyOct 29, 2026NCT07872904
- AI-Driven Metabolic Cohort in Overweight/Obese Chinese AdultsOct 27, 2026NCT07584330
- Translational Health Research Into Vascular and Neurocognitive Effects of Weight LossOct 26, 2026NCT07592546
- A Study of SA030 Injection in Overweight/Obese Participants With or Without Type 2 Diabetes Mellitus (T2DM)Oct 23, 2026NCT07479862
- A Single Ascending Dose and Multiple Ascending Doses Study of SYH2082 Injection in Healthy ParticipantsOct 23, 2026NCT07532655
- Multimodal Intervention for Weight Management and Health in the Elderly PopulationOct 20, 2026NCT07820774
- PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility StudyOct 20, 2026NCT07874828
- A Study of IBI3046 in Participants With Overweight or ObesityOct 19, 2026NCT07809945
Results posted4
- A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesNov 9, 2026NCT05936151
- The Feasibility and Preliminary Efficacy of the Mindful-Healthy Family Intervention With Rural FamiliesNov 6, 2026NCT05324969
- Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health InterventionNov 4, 2026NCT05249465
- A Study of CT-868 in Type 1 Diabetes MellitusOct 28, 2026NCT06062069
Stopped2
- The Impact of Continuous Glucose Monitoring on Glucose Variability and Weight Loss in Individuals With Prediabetes and ObesitySuspendedNov 4, 2026NCT07423065
- Physical Exercise Prehabilitation Program in mEtabolic suRgeryTerminatedOct 30, 2026NCT06889207
Newly registered69
- A Phase I Study to Evaluate Single and Multiple Subcutaneous Administrations of QLS2406-1 Injection in Chinese Adult Participants With Overweight and Obesity.Nov 16, 2026NCT07937787
- Mediterranean Longevity Diet and Fasting Mimicking Diet in Adolescents With Overweight or ObesityNov 16, 2026NCT07938268
- Pharmacokinetics, Safety, and Tolerability of DA-302168S Tablets in Participants With Varying Degrees of Renal Impairment and Normal Renal FunctionNov 16, 2026NCT07938515
- Impact of Dietary Diversity on Postprandial Insulin Secretion and MetabolismNov 16, 2026NCT07938788
- Effects of Wild Thyme Extract on Overweight and ObesityNov 16, 2026NCT07939425
Show 45 moreShow fewer
- The LITTLE OWLS Study (in German: "Kleine Eulen OWL"): Exploring the Early-life Microbiome Development and Physical and Mental Health Outcomes During Childhood.Nov 13, 2026NCT07934654
- Effects of "Exercise Snack" in Individuals With ObesityNov 13, 2026NCT07935473
- Aerobic Exergaming ( Wii ) Protocol : Influence on Reaction Time and Pulmonary Functions in Overweight ChildrenNov 13, 2026NCT07936331
- Intragastric Balloon and Time-Restricted Eating for Weight Loss in Adults With Overweight or ObesityNov 13, 2026NCT07936877
- Aerobic Exercise Added to Diaphragmatic Breathing for Nocturnal Enuresis in Overweight and Obese ChildrenNov 12, 2026NCT07930351
- Changes in Body Composition and Muscle Composition After GLP-1 Receptor Agonist Therapy in Patients With ObesityNov 12, 2026NCT07931560
- School- and Family-Based Lifestyle Programme for Primary School Children in Punjab, Pakistan: A Feasibility StudyNov 12, 2026NCT07932028
- The Purpose of This Study is to Learn About the Safety and Effectiveness of Berobenatide in Women With Urine Leakage and With Obesity or OverweightNov 12, 2026NCT07932925
- Lifestyle Strategies to Preserve Muscle and Reduce Cardiovascular Risk in Adults With Obesity Using GLP-1 Receptor AgonistsNov 12, 2026NCT07933393
- Effects of Thai Food-Specific Inhibition Control Training on Psychophysiological Outcomes in Thai Adults With ObesityNov 10, 2026NCT07928817
- A Study to Evaluate the Safety and Efficacy of Ecnoglutide Tablets in Chinese Participants With Overweight or ObesityNov 10, 2026NCT07929298
- The Impact of Incretins on Fat-free Mass, Muscle Strength and Functional CapacityNov 10, 2026NCT07929831
- A Single Ascending Dose and Multiple Ascending Dose Trial to Assess the Dose, the Efficacy and Oro-sensitivity of Two Modified Linoleic Acids NKS-3 and NKS-5Nov 9, 2026NCT07924267
- A Study to Investigate the Effect of Injection Site and Ethnicity on KAI-4729 Pharmacokinetics in Non-Asian and Asian Participants Living With Obesity or OverweightNov 9, 2026NCT07924761
- Determination of ED90 of Remimazolam Besylate Combined With Alfentanil for Gastroscopy Sedation in Obese PatientsNov 9, 2026NCT07925684
- Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 DiabetesNov 9, 2026NCT07926152
- Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous Presentations After Multiple DosesNov 6, 2026NCT07921316
- Effect of Probiotics on Insulin Sensitivity in Overweight and Obese PregnancyNov 6, 2026NCT07921940
- Lifestyle Interventions and Genetic Scores for Weight ManagementNov 6, 2026NCT07922005
- A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 DiabetesNov 6, 2026NCT07922330
- A Phase I Clinical Trial of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of UBT48128 Tablets in Healthy ParticipantsNov 6, 2026NCT07922798
- Effects of Sequential Therapy With Mexidol® (Intravenous) and Mexidol® FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional Magnetic Resonance Imaging and Biochemical Parameters in Patients With Chronic Cerebral Ischemia: A Comparison of Patients With and Without Metabolic DisordersNov 6, 2026NCT07923240
- A Study to Evaluate Efficacy and Safety of BGM1812 Injection in Overweight or Obese Participants Without DiabetesNov 5, 2026NCT07918625
- A Clinical Study Testing Enicepatide in Participants Living With Overweight or Obesity and Cardiovascular DiseaseNov 5, 2026NCT07918846
- Impact of Dyslipidemia on Metabolic Health of Adults With Overweight/Obesity (IDOM): A Study at the San Raffaele Hospital Center for Metabolic HealthNov 5, 2026NCT07919158
- A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)Nov 5, 2026NCT07919678
- A Study of LY4247147 in Participants With Obesity or Overweight Who Are Otherwise HealthyNov 4, 2026NCT07915245
- A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)Nov 4, 2026NCT07915609
- A Study of Zovaglutide (ZT002 Injection) in Participants With Hepatic Impairment and Healthy ParticipantsNov 4, 2026NCT07916194
- The Effect of Liraglutide on Body Weight, Body Composition, Ectopic Lipid Accumulation and Insulin Sensitivity in Subjects With Overweight or Obesity Without DiabetesNov 3, 2026NCT07913685
- Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)Nov 2, 2026NCT07908316
- ERCG vs Intensive Lifestyle Intervention for Weight Regain After GLP-1 RA DiscontinuationNov 2, 2026NCT07908823
- An Open Label Pilot Study Assessing the Impact of Chromium Picolinate Supplementation on Appetite and Cravings in Overweight IndividualsNov 2, 2026NCT07909109
- Effects of a Multispecies Probiotic on Metabolic, Liver, and Gut HealthNov 2, 2026NCT07909772
- Effects of Concurrent Training on Serum PCSK9 Levels in Adults With OverweightNov 2, 2026NCT07910916
- A Trial to Assess the Relative Bioavailability of Different Subcutaneous Formulations of AZD9550 and AZD6234Nov 2, 2026NCT07911514
- Transcutaneous Auricular Vagus Nerve Stimulation Combined With Lifestyle Intervention for Visceral Fat Reduction in Adults With Overweight or ObesityOct 30, 2026NCT07907029
- Oxytocin for Respiratory Compromise and Hypoventilation Induced by DrugsOct 29, 2026NCT07902752
- Sustaining Health After an Intensive Weight-loss Pro-grammeOct 28, 2026NCT07900178
- A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular RiskOct 28, 2026NCT07900633
- Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults With ObesityOct 28, 2026NCT07901777
- Mazdutide for Reducing Atrial Fibrillation Recurrence After Catheter Ablation in Obese PatientsOct 27, 2026NCT07897305
- Investigating the Effects of 24 Hour LEAP2 Infusion in Individuals With Overweight and ObesityOct 27, 2026NCT07897383
- Impact of Significant Surgical Reduction of Adipose Tissue on Plasma Levels and Genetic Expression of Adipokines Associated With Ischemic Heart Disease in Type I Obesity.Oct 27, 2026NCT07897682
- Testing Health-Related Interventions: Voices of Equity Needed to Overcome Weight-bias in Obesity-Cancer CareOct 27, 2026NCT07897890
and 19 more not listed
Studies
Recruiting first, then most recently updated. Showing 50 of 3,613. Browse all 3,613 → or search them.
- The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 DiabetesRecruitingNCT06144593Not applicable1 country
- Mediterranean Longevity Diet and Fasting Mimicking Diet in Adolescents With Overweight or ObesityRecruitingNCT07938268Not applicable1 country
- A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established Cardiovascular DiseaseRecruitingNCT07843472Phase 33 countries
- GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort StudyRecruitingNCT075889841 country
- Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat ChangeRecruitingNCT06325722Not applicable1 country
- Digital Resistance Training for Midlife Women Using GLP-1Not yet recruitingNCT07787533Not applicable1 country
- Exercise, Chronotype, and PrediabetesRecruitingNCT07389005Not applicable1 country
- A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or ObesityRecruitingNCT07243171Phase 1/21 country
- Pharmacokinetics, Safety, and Tolerability of DA-302168S Tablets in Participants With Varying Degrees of Renal Impairment and Normal Renal FunctionRecruitingNCT07938515Phase 11 country
- A Phase I Study to Evaluate Single and Multiple Subcutaneous Administrations of QLS2406-1 Injection in Chinese Adult Participants With Overweight and Obesity.Not yet recruitingNCT07937787Phase 1
- Effects of Akkermansia Muciniphila and Berberine Supplementation on Insulin Sensitivity in Night-shift WorkersRecruitingNCT07440147Not applicable1 country
- Effects of Wild Thyme Extract on Overweight and ObesityEnrolling by invitationNCT07939425Not applicable1 country
- Impact of Dietary Diversity on Postprandial Insulin Secretion and MetabolismNot yet recruitingNCT07938788Not applicable1 country
- Effects of Thai Food-Specific Inhibition Control Training on Psychophysiological Outcomes in Thai Adults With ObesityEnrolling by invitationNCT07928817Not applicable1 country
- Intragastric Balloon and Time-Restricted Eating for Weight Loss in Adults With Overweight or ObesityRecruitingNCT07936877Not applicable1 country
- A Study of SA030 Injection in Overweight/Obese Participants With or Without Type 2 Diabetes Mellitus (T2DM)RecruitingNCT07479862Phase 11 country
- The Effect of Oral Iron Supplements on Insulin and Glucose Metabolism in Overweight and Obese WomenRecruitingNCT07315282Not applicable1 country
- Effects of "Exercise Snack" in Individuals With ObesityRecruitingNCT07935473Not applicable1 country
- The LITTLE OWLS Study (in German: "Kleine Eulen OWL"): Exploring the Early-life Microbiome Development and Physical and Mental Health Outcomes During Childhood.RecruitingNCT079346541 country
- PRE-Pregnancy Weight Loss And the Reducing Effect on CHILDhood Overweight - AarhusRecruitingNCT05798494Not applicable1 country
- Lifestyle Strategies to Preserve Muscle and Reduce Cardiovascular Risk in Adults With Obesity Using GLP-1 Receptor AgonistsNot yet recruitingNCT07933393Not applicable1 country
- Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)RecruitingNCT07481747Phase 31 country
- Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)RecruitingNCT03407079Phase 21 country
- Changes in Body Composition and Muscle Composition After GLP-1 Receptor Agonist Therapy in Patients With ObesityNot yet recruitingNCT07931560
- The Purpose of This Study is to Learn About the Safety and Effectiveness of Berobenatide in Women With Urine Leakage and With Obesity or OverweightNot yet recruitingNCT07932925Phase 3
- How the Body Processes Sugar After Eating, in People With Different Body WeightsRecruitingNCT07690176Not applicable1 country
- The FaibaGo Study - Long-Term Weight Reduction Via Low-Threshold InterventionRecruitingNCT07036692Not applicable1 country
- A Two-part Study of Lembas Edge Evaluating Tolerability and Postprandial Glycemic ControlRecruitingNCT07711288Not applicable1 country
- HYPERtension Reduction Through WALKing Stairs Versus Brisk WalkingRecruitingNCT06952348Not applicable1 country
- Time Restricted Eating (TRE) in Bipolar DisorderRecruitingNCT07211217Not applicable1 country
- A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in People With Reduced Liver Function and Normal Liver FunctionRecruitingNCT07587710Phase 11 country
- The Impact of Incretins on Fat-free Mass, Muscle Strength and Functional CapacityRecruitingNCT079298311 country
- Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or ObesityRecruitingNCT07830329Phase 21 country
- Testing Just-in-Time Adaptive Interventions (JITAIs) to Prevent Goal Disengagement in Response to Weight RegainRecruitingNCT07708064Not applicable1 country
- A Study to Evaluate the Safety and Efficacy of Ecnoglutide Tablets in Chinese Participants With Overweight or ObesityNot yet recruitingNCT07929298Phase 21 country
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 DiabetesRecruitingNCT07351058Phase 322 countries
- Probiotics, Cognition and Metabolic Health in Young Adults With Overweight or ObesityRecruitingNCT07073781Not applicable1 country
- A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes MellitusRecruitingNCT07776509Phase 311 countries
- A 12-week Field Trial of the Movámonos Physical Activity Support ProgramNot yet recruitingNCT07561996Not applicable
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 DiabetesRecruitingNCT07351045Phase 321 countries
- Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 DiabetesNot yet recruitingNCT07926152Not applicable1 country
- A Study to Investigate the Effect of Injection Site and Ethnicity on KAI-4729 Pharmacokinetics in Non-Asian and Asian Participants Living With Obesity or OverweightNot yet recruitingNCT07924761Phase 11 country
- Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or OverweightRecruitingNCT07871409Phase 32 countries
- Determination of ED90 of Remimazolam Besylate Combined With Alfentanil for Gastroscopy Sedation in Obese PatientsRecruitingNCT07925684Not applicable1 country
- A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes MellitusRecruitingNCT07775404Phase 35 countries
- Exercise Training and Vitamin D MetabolismRecruitingNCT07300332Not applicable1 country
- Metabolic Health, Bones and Nuts During Weight Loss in AdultsRecruitingNCT06949280Not applicable1 country
- Effectiveness of a 10-week Multicomponent Intervention Combined With Parent Education on Binge Eating Behavior in Children and AdolescentsNot yet recruitingNCT07301541Not applicable1 country
- A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 DiabetesNot yet recruitingNCT07922330Phase 32 countries
- Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous Presentations After Multiple DosesNot yet recruitingNCT07921316Phase 1